Trials / Recruiting
RecruitingNCT06481943
A Prospective Research Investigation of Ischemia Using MCG
A Prospective Research Investigation of Ischemia Using SandboxAQ Magnetocardiography Device
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- SB Technology, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sponsor MCG device (CardiAQ) | Unshielded magnetocardiography device for measuring cardiac magnetic fields |
Timeline
- Start date
- 2024-07-11
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2024-07-01
- Last updated
- 2025-10-21
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06481943. Inclusion in this directory is not an endorsement.